GCU health research paper shortlisted for BMJ Awards 2015

24 February 2015

GCU health research paper shortlisted for BMJ Awards 2015

Researchers from Glasgow Caledonian University (GCU) have been shortlisted for best UK Research Paper in the BMJ Awards 2015.

Professor Suzanne Hagen, Programme Director at the Nursing, Midwifery and Allied Health Professions Research Unit, and her team have been nominated for research along with papers from the University of Southampton, Imperial College London, the University of Oxford and the University of Cambridge.

Professor Hagen’s report on ‘Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial’ reported the findings of the largest trial to date that pelvic floor muscle exercises are an effective means of treating prolapse.

The Nursing, Midwifery and Allied Health Professions Research Unit, where the research was undertaken, is funded by the Chief Scientist Office (CSO) of the Scottish Government and hosted jointly by Glasgow Caledonian University and the University of Stirling.

The POPPY trial was funded by the CSO’s Health Services and Population Health Research Committee.

The Awards will take place on May 6 at Park Plaza Hotel.

In the recent Research Excellence Framework (REF) 2014, GCU was ranked in the top 20 in the UK for allied health research at world-leading (4*) and internationally excellent standards (3*).

89% of GCU’s allied health professions research is world-leading and internationally excellent. All of the University’s impact submission for allied health professions was judged to be in the highest categories, ranking GCU as one of the leading universities in the UK for the societal impact of its applied research in health.

Research in areas including increasing HIV testing among vulnerable populations; healthcare associated infections; effective treatments for women with prolapse; and personalised foot orthoses highlight GCU’s significant impacts on health policy and services, commercial organisations and patients.

Share/Save/Bookmark

Latest from Twitter